Lung Cancers Withdrawn Phase 1 Trials for Panobinostat (DB06603)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Withdrawn1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01160731Panobinostat, Etoposide, and Cisplatin as First-Line Therapy in Treating Patients With Extensive-Stage Small Cell Lung CancerTreatment